Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2021-06-21 Foreign Filer Report
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
6-K
Foreign Filer Report
2021-06-21 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, the average price, and the total value, as well as the updated treasury share count. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2021-06-21 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a company announcement detailing specific transactions executed under a share buy-back program, including the number of shares purchased, average prices, and total value. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2021-06-21 English
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 99% confidence The document text consists almost entirely of tables showing trading activity (Volume, Price, Venue, Time CET) for a company named 'Genmab'. The entries in the tables are numerical codes (e.g., 1, 2, 18, 19, 20, 21, 22, 23, etc.) associated with transaction types, which strongly suggests this is a record of insider transactions or director dealings, often reported to exchanges. Reviewing the provided definitions, the category 'Director's Dealing (Code: DIRS)' is the most appropriate fit for reporting personal share transactions by directors and executives, even though the codes themselves are not explicitly labeled as 'DIR' or 'Form 4' equivalents. The presence of codes like '18' (which appears frequently and often corresponds to insider transactions in various reporting schemas) and the overall structure points away from formal financial reports (10-K, IR, ER) or meeting materials (AGM-R, DEF 14A). Since DIRS is specifically for director/executive transactions, it is the best match.
2021-06-21 English
6-K
Foreign Filer Report
2021-06-16 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 100% confidence The document is titled 'Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons'. It explicitly references Article 19 of Regulation No. 596/2014 (Market Abuse Regulation), which mandates the disclosure of insider/director dealings. This falls directly under the 'Director's Dealing' category.
2021-06-16 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.